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ABSTRACT 
 
Reduced GABAergic signaling at the axon initial segment decreases vigilance 
state transitioning 
 
by 
 
Austin John Boren 
 
Dr. Rochelle Hines, Examination Committee Chair 
Assistant Professor of Psychology 
University of Nevada, Las Vegas  
 
Sleep is a highly regulated homeostatic process that is disrupted in an estimated 
50-70 million Americans. Regulation of sleep depends upon coordinated signaling of 
multiple neurotransmitter systems. In particular, inhibitory gamma-aminobutyric acid 
(GABA) signaling is required to suppress wake-active brain regions in order to initiate 
and maintain sleep states. GABA type A receptors (GABAARs) are ionotropic receptors 
with subunit compositions uniquely enriched on subcellular domains of target cells. α2 
subunit-containing GABAARs are the primary target of GABA released onto the axon 
initial segment (AIS), a site critical for phasing the oscillatory activity of cortical cells. α2-
containing GABAARs have previously been implicated in the initiation and maintenance 
of sleep. To determine the contribution of GABAergic singling at the AIS to regulation of 
sleep, we used behavioral and electroencephalographic measures to assess sleep in a 
mouse featuring a loss of inhibitory synapses onto the AIS (Gabra2-1). Reduced 
GABAergic input to the AIS results in a persistent increase in the delta frequency range 
in Gabra2-1 mice, suggesting an alteration in sleep regulation. Analysis of long term 
recordings demonstrate that Gabra2-1 homozygous mice spend less time asleep during 
iv 
subjective night, and also have reduced vigilance state transitions. Gabra2-1 
homozygous mice show a loss of free running rhythm when housed in constant 
darkness, and fail to homeostatically respond to 24 hours of sleep deprivation. These 
studies demonstrate a role for α2 containing GABAARs in sleep initiation, transitions, 
and the response to sleep challenges, providing critical information for the refinement of 
sleep therapies. 
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CHAPTER 1 
INTRODUCTION 
The central nervous system (CNS) oscillates at multiple timescales allowing for 
temporal patterning of complex behavior. The cyclic patterning of sleep is considered to 
be a master oscillatory pattern as it regulates many homeostatic functions1. Disruptions 
to its progression results in primary sleep disorders impacting 50-70 million Americans 
while sleep disturbances are a common symptom of CNS disorders2,3. Homeostatic 
regulation of sleep depends on the establishment and maintenance of oscillatory 
patterns occurring on relatively long time scales, including the circadian rhythm. In 
humans, the circadian rhythm is an oscillation taking about 24 hours that determines the 
timing of sleep 4. Misalignment of the circadian rhythm to the natural light/dark cycle 
results in circadian rhythm disorders5. While the circadian rhythm regulates the timing of 
the sleep/wake cycle, a shorter 90-mintue oscillation, the basic rest activity cycle 
(BRAC)6, further regulates the time in which we are sleeping, delimiting the known sleep 
stages. Determined by the predominate electroencephalographic (EEG) signal present, 
sleep is divided into non-rapid-eye-movement (NR) and rapid-eye-movement sleep (R). 
NR sleep, consuming about 75% of our sleeping hours, is dominated by the presence of 
slow wave activity in the delta frequency range (0.5-4.0 Hz) representing large, highly 
synchronized networks of neurons 7. In contrast R, taking up about 25% of our sleeping 
hours, is dominated by a high delta/theta ratio along with the presence of gamma (30-
100Hz) which is associated with network activity, allowing for dreams 8. The 
establishment and maintenance of oscillatory patterns essential to sleep regulation 
depends on GABAergic signaling inhibiting wake-promoting regions9 at appropriate 
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times. There are several lines of evidence suggesting a pivotal role for GABAergic 
signaling in sleep onset and maintenance with the first coming from the discovery of 
sleep inducing drugs. Many sleep drugs were discovered without knowing their 
functional properties, yet later it came to light that the majority of them acted by 
increasing the affinity of gamma-aminobutyric-acid (GABA) to GABA receptors10. 
Further, when specific GABA receptor subtypes are render insensitive by point 
mutation, these compounds they lose their sedative qualities11,12. Lastly, it is found that 
increased GABAergic signaling in distinct brain regions either promotes or reduces 
sleep10,13. Taken together, these studies suggest a central role for GABA and GABA 
receptors in sleep and sleep regulation.  
A large body of work has since demonstrated that GABAergic neurotransmission 
is diverse in terms of cellular origin, postsynaptic subcellular target, and molecular 
composition, giving rise to diverse functional implications14–16. One key role of 
GABAergic singling is the patterning of excitatory output into oscillatory states, that 
support specific behavioral states, including active and relaxed waking, as well as 
stages of sleep17,18. The potential to control oscillatory activity is particularly true of 
GABAergic contacts on the soma and axon initial segment (AIS) that exert powerful 
control over pyramidal cell activity by virtue of proximity to the site of action potential 
generation19.  
The primary target of synaptically released GABA is the ionotropic GABA type A 
receptor (GABAARs)20. Each GABAAR contains a combination of five out of 19 possible 
subunits: α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ⍴(1-3), resulting in 26 known human 
isoforms14. The majority of functional GABAARs expressed in the brain are composed of 
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two α, two β, and one γ subunit21. Although subunit composition is relatively uniform 
amongst GABAARs, the specific subunit composition plays a significant role in 
determining function. α subunits are thought to be important determinants of localization 
and consequent function, with α1-3 subunits being enriched in receptors clustered at 
specific postsynaptic targets, and α4-6 enriched in extra synaptic receptors21. GABAARs 
containing the α1 subunit are found to be enriched at axo-somatic synapses 
postsynaptic to parvalbumin positive basket cells 22 while α2/3 containing GABAARs are 
enriched postsynaptic to cholecystokinin-expressing positive basket cells15,23. α2 
containing GABAARs are also notably enriched along the AIS, postsynaptic to 
parvalbumin positive chandelier cells24–26, a site thought to play a pivotal role in shaping 
excitatory output27.  
The advent and subsequent study of subunit selective sleep compounds 
suggests GABAARs containing the α2 subunit may be central to sleep regulation. 
Classic sleep agents such as diazepam are non-selective as they act on all 
benzodiazepine sensitive GABAARs including receptors containing the α1, α2, α3, or α5 
subunit28. Interestingly, the α1/α2 selective compound zolpidem (Ambien) action alone 
is sufficient for inducing certain aspects of sleep. Specifically, zolpidem decreases sleep 
latency and increases sleep time29,30. In addition, selective application of zolpidem in the 
tuberomammillary nucleus is sufficient for the effects of zolpidem on sleep latency, and 
zolpidem application in the frontal cortex can reduce sleep latency in a top down 
fashion30. Further, expression of the GABAAR containing the α2 subunit has been 
documented in hypothalamic and pontine regions31, including on histaminergic neurons 
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of the tuberomammillary nucleus32,33 yet its precise role in sleep regulation is yet to be 
demonstrated.  
Previous work has identified a 13 amino acid sequence within the large 
intracellular loop of the GABAAR α2 subunit that is essential for trafficking to the AIS34. 
Our recent study showed that the α1/3 and α2 loops have complementary interaction 
strengths with gephyrin and collybistin, with the α2 loop and collybistin SH3 domain 
having a unique high affinity interaction35. Based on the indication of the α2 loop in 
collybistin interaction and AIS localization, we generated and characterized a novel 
strain, Gabra2-1, that expresses a 13 amino acid substitution from the α1 subunit into 
the α2 subunit large intracellular loop(Figure 1 A)35. Total expression of α2 was 
increased in the cortex of Gabra2-1 mice, but collybistin was dramatically reduced 
(Figure 1 B). Assessment of inhibitory synapses targeting the axon initial segment 
revealed a loss of α2 enrichment and VGAT positive contacts (Figure 1C)35.  
In the present study we use Gabra2-1 mice as a tool to probe the functional 
impact of AIS GABAergic signaling in oscillatory activity and behavioral output, focusing 
on sleep architecture, homeostasis, and the response to sleep challenges. We 
demonstrate that reduced α2 signaling at the AIS in Gabra2-1 homozygous mice results 
in a striking increase in baseline EEG power that is maintained across the 24 hour 
period. Spectral analysis demonstrates that the increase in EEG power is restricted to 
the delta frequency ranges during the vigilance state of NREM sleep. Interestingly, this 
manifests as a reduction in time spent asleep during subjective night. Further, Gabra2-1 
homozygous mice also show reduced transitions into and out of specific stages of 
sleep. Gabra2-1 homozygous mice also have altered responses to sleep challenges, 
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including an inability to maintain free running circadian rhythmicity in the absence of 
light as a zeitgeber, and a blunted homeostatic response to sleep deprivation.      
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CHAPTER 2 
REVIEW OF RELATED LITRATURE 
Inhibition, γ-aminobutyric acid and γ-aminobutyric acid receptors 
First localized at nerve terminals in the 1970’s using radioactive labelling and 
complementary electron microscope autoradiography techniques, GABA was 
recognized as the primary inhibitory neurotransmitter of the CNS36. This 
neurotransmitter is produced by two enzymatic reactions, GAD65 and GAD67 acting on 
glutamate37. The resulting GABA neurotransmitter is loaded into synaptic vesicles by 
vesicular neurotransmitter transporter (VGAT) and is then ready to be released into the 
synaptic cleft by presynaptic Ca2+ signaling.  
Once GABA is released into the synaptic cleft it can act upon ionotropic as well 
as metabotropic GABA receptors. Discovered by professor Norman Bowery in 198138, 
metabotropic G-protein-coupled γ-aminobutyric acid, B-type (GABAB) receptors, found 
both pre- and post-synaptically, are responsible for the tonic inhibitory action of GABA. 
GABAB receptors take relatively more time than other GABA receptors to act due to the 
time it takes for G-protein-coupled receptors to activate the necessary components of 
the pathway and effect downstream inhibition. When GABA binds to GABAB in 
presynaptic receptors it inhibits presynaptic Ca2+ channels effectively reducing 
neurotransmitter release while activation of postsynaptic GABAB receptors acts on 
several inward rectifying K+ channels hyperpolarizing neurons and shunting excitatory 
input39,40. Although mutations to GABAB receptors are implicated in disease states, it is 
the phasic form of inhibition and its associated receptor type that is implicated in sleep 
disorders.  
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GABAARs are the primary source of phasic inhibition in the adult CNS. GABAARs 
have active binding sites for psychoactive drugs including benzodiazepines, 
barbiturates, steroids, anesthetics, and anticonvulsants41. GABAARs are 
heteropentameric ligand gated ion channels allowing Cl- to pass through the central 
canal when activated. Each GABAAR is constructed from a combination of five subunits 
including α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ⍴(1-3)42 with 26 human isoforms being 
identified thus far42. 
Signaling properties, localization, and expression of GABAARs is determined by 
subunit composition. When considered globally, GABAARs containing α1, β2, and γ2 
subunits are the most highly expressed across all brain regions42. Regionally, receptors 
containing α1, β1, β2, and β3 subunits are homogenously expressed while receptors 
containing α2, α3, α4, α5, α6, γ1 and δ subunits are found to be heterogeneously 
expressed, primarily in the forebrain areas41. Allowing for precise spatial and temporal 
modulation of excitatory signaling, GABAARs are also differentially expressed at 
subcellular locations postsynaptic to specific interneurons synapsing on dendrites, 
axons, and the cell body15. Receptors containing the α1 subunit are found at most 
GABAergic synapses with the highest concentration at inhibitory synapses on dendrites 
and soma postsynaptic to parvalbumin positive basket cells25.  Receptors containing the 
α2 subunit, more limited in their expression, are found to be enriched postsynaptic to 
chandelier cells synapsing at the AIS43. Analysis of subunit concentration at the synaptic 
level has shown that GABAARs found at extra-synaptic sites generally contain α4 or α6 
subunits while receptors found at synaptic sites generally contain α1, α2, or α344,45. 
Given the highly specialized nature of GABAARs distribution, altered inhibitory 
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localization and expression is thought to underlie diseases of neuronal dysregulation, 
highlighting the importance of discovering the signaling molecules and proteins involved 
in their trafficking and expression46.  
Several receptor-associated, adhesion, and scaffolding proteins are suspected to 
interact with GABAARs subtypes in unique ways allowing for differential expression and 
localization. Although the full signaling pathway for trafficking of all GABAARs subtypes 
has yet to be discovered, a few key proteins have been identified as central to this 
process. Gephyrin, a scaffolding protein necessary for the clustering of several receptor 
types including glycine receptors is found to be highly co-localized with GABAARs47,48. 
The Moss lab has demonstrated binding motifs on GABAARs containing α1, α2, and α3 
subunits for gephyrin necessary for appropriate receptor clustering49–51. Recent work 
from the Moss lab demonstrates the necessity of another scaffolding protein, collybistin, 
in the trafficking and clustering of GABAARs containing the α2 subunit onto the AIS35.  
In the present study we aim to determine the contribution of GABAARs containing the α2 
subunit at the AIS to the phenomena of sleep, as this synaptic sight, discussed in the 
next section, is thought to be central to network functioning. 
     
The axon initial segment  
Excitatory principal neurons are the fundamental cells of neuronal 
communication in the CNS. These specialized cells have an atypical structure, one of 
asymmetry, endowing them with specialized communication properties. First proposed 
by Santiago Ramon y Cajal, along with the neuron doctrine, the law of dynamic 
polarization states that information flows along the principal neuron in only one 
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direction, driven by cellular polarization52,53. Under this paradigm, the neuron can be 
seen as a simple input-output device. The dendrites act as an input device, sensing a 
signal in the form of a chemical messenger from up-stream neurons. This signal is then 
transduced to the cell body. If polarity is sufficiently shifted, an action potential (AP) is 
fired, the signal is then transduced along the axon where the terminal buttons act as an 
output device. This stroke of insight by Cajal inspired generations of biologist to study 
and define the cellular structures, receptors, and chemical messengers underlying this 
fundamental principal of neuronal communication.  
In landmark experiments conducted by Hodgkins and Huxley on the signaling 
properties of the giant squid axon, they described the principal electrical component of 
neuronal communication, namely the AP54. The ‘decision point’ determining if an AP is 
fired occurs in a specialized subcellular compartment found just distal of the axon hillock 
and ending at the first section of myelination, the AIS43. Similar to the nodes of Ranvier, 
the AIS is studded with ion channels allowing for rapid depolarization and repolarization. 
Three forms of Na+ channels are highly enriched on the AIS including Nav1.155, 
Nav1.256, and Nav1.657 allowing for rapid depolarization and AP initiation. K+ channels 
including Kv1.1 and 1.2 are enriched at the AIS for rapid repolarization58.       
Modulation of AP’s occurs via GABAergic interneurons synapsing at the AIS. 
Specifically, the chandelier cell with its striking morphology of highly branched axonal 
arbors are found to synapse exclusively at the AIS59,60. These specialized interneurons 
are thought to contribute to the generation of neuronal networks as their highly 
branched arbors reach out and synapse with hundreds of principal cells61 at the AIS 
allowing them to effectively modulate the timing of AP’s across neuronal networks62. Of 
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interest to the current study, chandelier cells, or axo-axonic cells, are found to have a 
high postsynaptic density of GABAARs containing the α2 subunit suggesting this GABAA 
receptor subtype may be central to network functioning62.  
     Given the significant role the AIS, axo-axonic cells, and GABAARs containing the 
α2 subunit play in network functioning, disruptions to these processes are thought to 
underlie common disorders of the CNS. It has been demonstrated that axo-axonic 
synapses are reduced at the epileptic foci63 and are thought to underlie continued 
dysregulated excitation in epilepsies. Further, altered axo-axonic innervation and α2 
distribution are thought to disrupt the excitatory to inhibitory ‘balance’64 and contribute to 
schizophrenia and neurodevelopmental disorders including autism spectrum65,66. The 
full contribution of altered AIS morphology, axo-axonic cell synapsis, and distribution of 
GABAARs containing the α2 subunit to these common disorders is still an open scientific 
question.  
          Very little is known about the contribution of the AIS and axo-axonic cells to the 
processes of sleep. Sleep is dependent and defined by specific oscillatory activity 
discussed in the next section. Given the role axo-axonic cells play in patterning 
pyramidal output into oscillatory activity, it is likely their signaling properties contribute to 
various oscillations of sleep. In a study conducted by Massi et. al., in 2012 they suggest 
axo-axonic cells and basket cells may contribute to NREM and REM sleep oscillations, 
including spindle and gamma oscillations67. It is part of the aim of this study to 
determine the impact of a loss of GABAARs containing the α2 subunit at the AIS to 
sleep and its natural oscillatory progression.   
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GABAergic contribution to sleep, circadian, and ultradian rhythms 
 The circadian rhythm is an oscillation taking about 24 hours in humans that 
entrains the biological system to the environment allowing for timely behavioral output. 
In an elegant paper published by Aschoff in 1965, he observed circadian rhythmicity in 
humans under deprived conditions to understand the role of environmental input, or 
zeitgebers, on its cyclic duration or τ. He placed participants (including himself) in an 
environment lacking all zeitgebers and found that the τ of a free-running circadian 
rhythm in humans is an average of 25.9 hours68. Further, he described the impact of 
desynchronization, the mismatch between sleep and circadian rhythmicity, and its 
impact on psychological well-being. Subjects reported more positively on days in which 
these processes were aligned. A landmark paper published in 1982 by Borbely A.A. 
further refined our understating of the circadian rhythm and how it interacts with sleep. 
In this paper titled the ‘Two process-model of sleep regulation’ it is proposed that the 
sleep/wake cycle (Process S) and the circadian pacemaker (Processes C) oscillate at 
different timescales, yet interact to define sleep wake activity. In summary it is 
suggested that Processes S is driven by increased sleep pressure caused by prior 
wakefulness and that it is entrained to the light dark cycle by Process C4. This model is 
still used today to study how Process S and C interact. Process S is established by 
sleep pressure which is assessed by EEG slow wave activity (SWA). Many EEG studies 
have shown that SWA, the hallmark of ‘restorative’ sleep, is modulated by prior 
wakefulness69–71 with increased prior wakefulness resulting in higher levels of SWA. 
These data suggest that accumulation and dissipation of sleep pressure contribute to 
the cyclic nature of Process S. Process C is established by a complex feedback system 
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taking place in the suprachiasmatic nucleus which interacts with the zeitgeber light72 
The progression of Process C is assessed by levels of melatonin and core body 
temperature, with high levels of melatonin and reduced core body temperature 
indicating a higher probability of sleep initiation73. Described by Nathaniel Kleitman in 
1963 by studying infant feeding patterns, the sleep/wake cycle is further modulated by 
the basic rest activity cycle (BRAC)74. The BRAC is an ultradian rhythm (a cycle less 
than a day and greater than an hour) that determines our activity level while awake and 
drives the progression of sleep stages while asleep6. That is the progression from non-
rapid-eye-movement (NREM) to rapid-eye-movement sleep (REM), occurring 6-9 times 
a night. The interaction of these exogenously and endogenously generated cycles allow 
for appropriate behaviors responses at appropriate times.  
Driven by these early studies, biologists have worked to understand the regions 
of the brain and neuronal progenitors of sleep. Sleep is a brain-wide process with a few 
key areas and neuronal types contributing to its onset and maintenance. The 
hypothalamus houses most of the regions thought to control vigilance, projecting their 
signal across the cortex to promote wakefulness or being suppressed to induce sleep. 
Within the hypothalamus, the ventrolateral preoptic nucleus (VLPO) projects onto the 
tuberomammillary nucleus (TMN). The VLPO houses GABAergic neurons which 
increase their firing rate at sleep onset75. The TMN houses histaminergic neurons, 
which when inhibited by the VLPO no longer release histamine, a wake promoting 
neurotransmitter, across the cortex allowing for sleep10. Other areas including the 
pedunculopontine and laterodorsal tegmental nuclei, housing cholinergic neurons, 
which act via another wake promoting neurotransmitter acetylcholine, are found to be 
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inhibited during sleep as they have been shown to be inactive during times of NREM76. 
Other distributed regions work in concert with the VLPO to inhibit wake promoting areas 
allowing humans to fall asleep in mere minutes. This observation led to Saper’s ‘flip-flop’ 
model of sleep onset77. This model suggests reciprocal inhibition from several sleep 
promoting areas creates an integrated network that can be turned off rapidly for quick 
vigilance state transitions.  
Given that all of the above mentioned processes depend on GABAergic 
inhibition, it has long been a challenge to discover the contribution of GABAAR subtypes 
to sleep. Classic sleep drugs including benzodiazepines are positive allosteric 
modulators, increasing GABA’s action on GABAARs, inducing sedation and sleep. 
Although the action of these classic sleep compounds indicates that GABAergic 
signaling is central to sleep, they do not inform us about receptor subtype contribution 
as they act on all benzodiazepine sensitive GABAAR including α1, α2, α3, and α528. The 
discovery of selective sleep compounds has begun to reveal the specific contribution of 
GABAARs subunits to sleep. The α1/α2 selective compound Zolpidem (Ambien) is the 
most prescribe sleep medication in the United States. This drug is known to decrease 
sleep latency and increase NREM time78. Clarifying the action of zolpidem, studies have 
shown an enrichment of GABAARs containing the α1/α2 subunit in the TMN79,80. 
Further, an electrophysiological study from Sergeeva’s lab demonstrated the necessary 
action of α1/α2 in the TMN for the action of benzodiazepines81. Given the selective 
action of zolpidem, evidence that GABAARs containing the α2 subunit are enriched in 
the TMN, and that they contribute significantly to benzodiazepine’s action in the TMN, 
we are currently using IHC to investigate the colocalization of α2 with histaminergic 
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neurons in the TMN as this may be mechanistic to sleep disturbances observed in the 
Gabra2-1 mouse model.  
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CHAPTER 3 
MATERIALS AND METHODS 
Subjects 
          Male mice bread at UNLV were group housed under a 12 hour light cycle (0700; 
lights on), constant temperature, and access to food and water ad libitum. All animal 
studies were performed under protocols approved by the Institutional Animal Care and 
Use Committee of University of Nevada Las Vegas. 
 
Genetic strategy 
          The Gabra2-1 mouse was generated by substitution of amino acids 358-375 from 
the large intracellular loop spanning transmembrane 3 and 4 of the GABAARs 
containing the α2 subunit with those of GABAARs containing the α1 subunit using 
homologous recombination in ES cells (Figure 1 A). Offspring were probed for the 
transgene using PCR with primers spanning the intronic region containing the remaining 
loxP site(SI Figure 1 A). Nontransgenic litter mates were used as controls in all 
experiments. 
 
Western blotting 
          Rapidly harvested whole brain tissue was homogenized in TEEN buffer (50mM 
Tris-HCL, 1mM EGTA, 150mM NaCl) with the addition of a protease inhibitor from 
Roche Applied Science. Resulting protein concentration was determined by BCA assay 
(Pierce). In preparation for blotting, samples were heated to 65°C in SDS page sample 
buffer with 10% ß-mercaptoethanol for 15 minutes and subject to SDS page 
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procedures. Resulting western blot signal were detected using ECL. Quantification of 
specific protein levels were determined by densitometry when normalized to actin 
densitometry results utilizing image J software.  
 
Immunohistochemistry 
          For histology, mice were transcardially perfused with periodate lysine 
paraformaldehyde (PFA) fixative solution. Following PFA fixation, brains were sectioned 
at the thickness of 30um with a cryostat and incubated in blocking solution (2.5% 
Bovine Serum Albumin, 5% Normal Goat Serum, 0.1% triton-X, 0.02% sodium azide in 
PBS) for 45 minutes. Sections were then incubated in primary antibody diluted in 
modified blocking solution (2% Normal Goat Serum) overnight at 4°C. Following 
washing, sections were then incubated in secondary antibody diluted in modified 
blocking solution for 1 hour at room temperature.   
 
Electroencephalographic surgery and data collection 
          Mice were implanted with chronic electroencephalographic (EEG) devices under 
isoflurane anesthesia. Two cortical EEG electrodes (stainless-steel screws) were placed 
in the frontal and parietal areas. Reference and ground electrodes are placed caudally. 
EMG electrodes were placed bilaterally in the dorsal nuchal musculature. All electrodes 
were soldered to an EEG/EMG headmount (Pinnacle Technology) which was then 
anchored to the EEG, reference, and ground electrodes with dental cement. The mice 
were sutured, given a bolus of lactated ringer solution, individually housed, and 
monitored for pain during recovery. 48 hours prior to data collection mice were 
17 
 
habituated to circular Plexiglas recording chambers (Pinnacle Technology) with a 
preamplifier connecting the chronic headmounts to a data acquisition device (Pinnacle 
Technology) via a micro-connector. During data collection, the electrical signal was 
acquired and stored for later offline analysis by a computer-based system using Sirena 
Acquisition software (Pinnacle Technology). EEG was sampled at a resolution of 250Hz 
and band passed at 100Hz. 
 
Vigilance state scoring 
          Ongoing vigilance was determined by assessment of EEG records in part by the 
software SleepSign for Animals (KESSEI COMTEC CO.) Each EEG record was binned 
in 8 second epochs and then screened using the following thresholding parameters: 
high EMG integral to detect wake (W), high FFT delta_power to detect non-rapid-eye 
movement sleep (NR), and high FFT theta_ratio to detect rapid-eye-movement sleep 
(REM). Resulting analysis (~90% accurate) was then confirmed by an expert in 
vigilance-state scoring who visualized each 8s epoch to determine the sate based on 
the following parameters: W was determined by high frequency and low amplitude EEG 
activity accompanied by high EMG activity, NR by low frequency and high amplitude 
EEG activity with little to no EMG activity, and REM by high frequency and low 
amplitude EEG activity with no EMG activity. Epochs with non-gaussian waveform were 
discarded as artifact. No file contained more than 1% artifact.  
 
24 hour baseline electroencephalographic assessment 
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          EEG recordings were made after habituation in chambers as described above. 
Spectrograms were generated from text files using a custom script for MATLAB. To plot 
relative power in frequency ranges from 0-30Hz, variance was reduced amongst 
surgical implants by normalization to the average from 0-100Hz within animal for a 
given analysis period (24 hours, ZT 12-0, and ZT 12-24). To plot vigilance state 
dependent relative power, data was normalized within animal to the average power from 
0-100Hz of the vigilance state being assessed (W, NR, or R). Amount of time spent in 
each vigilance state is expressed as a percent of the total analysis time (24 hours, ZT 
12-0, and ZT 12-24). A bout is defined as contiguous epochs scored as the same 
vigilance state while a transition is defined by a switch amongst ongoing vigilance state.  
 
Behavioral measures 
          For activity analysis, diurnally entrained mice were individually housed in 
metabolic activity chambers allowing for measurement of activity by beam break. 
Activity was measured for a total of 28 days. For the first 14 days mice where kept 
under diurnal conditions. On day 15 through day 28 mice were housed under constant 
darkness conditions to measure free running circadian rhythmicity. Visual placement 
tasks were created using the modified SHIRPA protocol. For sleep deprivation (SD) 
measures, mice underwent EEG/EMG surgery and were allowed to recover as 
described above. Prior to experimental recordings animals were habituated to recording 
chambers for 48 hours (days 1 & 2) as described above. Baseline recordings began at 
zeitgeber time (ZT) 0 (0700/light onset) on the third day and ended at ZT 0 on the fourth 
day. Beginning at ZT 0 on the fourth day animals underwent SD for 24 hours using the 
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gentile handling method. As previously described71 gentile handling protocols were 
initiated when animals began to display a sleeping posture (no movement and lowered 
head). Gentile handling procedures induced sleep disruption by introduction of novel 
objects, tapping on the cage, or gentile touch with an inflated surgical glove. These 
procedures were used to reduce stress caused by directly touching the animals. The 
recovery period began with cessation of SD procedures at ZT 0 on the fifth day. 
Recovery recordings were made for a total of 24 hours (day 5) allowing for sleep ad 
libitum. A simplified timeline is provided below. Data was scored for vigilance states as 
described above.  
 
 
              Sleep deprivation experimental timeline  
 
Statistical analyses 
          Statistical analyses were performed using SigmaPlot 12.5 software. Differences 
amongst cFFT plots, vigilance state percent time analysis, and transition assessment 
were determined by within-subject repeated measure two-way ANOVA. Total transitions 
during the ZT 0-12 and ZT 12-24 were assessed by one-way ANOVA. Significant main 
effects and interactions were further examined using Bonferroni t-test post hoc analysis. 
The significance threshold for all test was set at 0.05.  
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CHAPTER 4 
EXPERIMENTAL HYPOTHESES 
1. To test the hypothesis that reduced α2 signaling at the AIS will impact 
baseline electroencephalographic activity. Evidence suggests α2  signaling at 
the AIS is central to the patterning of excitatory pyramidal output into oscillatory 
states. cFFT and spectral assessment of 24 hour EEG recordings will allow for 
the determination of the impact of a loss of α2 at the AIS to the generation of 
specific oscillatory states which can be correlated to behavioral states.  
 
2. To test the hypothesis that reduced α2 signaling at the AIS will result in 
abnormal sleep architecture. Sleep homeostasis depends on integration of 
neuronal networks across CNS regions. Given the localization of α2 at the AIS 
allowing for modulation of AP initiation, we suspect a reduction in expression will 
disrupt homeostatic progression of sleep. Sleep scoring of 24 hour EEG 
recordings will allow for the analysis of sleep architecture across the circadian 
cycle.  
 
 
3. To test the hypothesis that reduced α2 signaling at the AIS will alter 
homeostatic response to sleep challenges.  Finally, if α2 contributes to the 
homeostatic regulation of sleep as suspected, we expect to find an altered 
homeostatic response to sleep challenges. Light and sleep deprivation will allow 
us to test this at the level of the circadian rhythm and homeostatic regulation of 
sleep pressure.  
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CHAPTER 5 
RESULTS 
Reduced α2 signaling at the axon initial segment increases baseline 
electroencephalographic power across a 24 Hour period 
 Previous analysis of EEG recordings made in adult Gabra2-1 homozygous mice 
revealed an increase of power in the delta frequency range (0.5-4Hz) over the course of 
a short recording period35. Given this, our first goal was to elucidate if the observed 
increase of delta power in Gabra2-1 homozygous mice is present throughout the 
sleep/wake cycle. To answer this question, we examined a 24 hour period of continuous 
EEG recordings made from freely moving wildtype, Gabra2-1 heterozygous, and 
homozygous mice. Qualitative spectrograms representing individual 24 hour baseline 
EEG records (Figure 2 A-C) suggested that Gabra2-1 homozygous mice have 
increased power in low frequency ranges. To assess this quantitatively, we applied a 
cFFT to the EEG data allowing us to plot relative power in frequencies ranging from 0-
30Hz for the entire 24 hour recording period (Figure 2 D). While the Gabra2-1 
heterozygous mice had significantly increased power when compared to wildtype 
controls in a very limited set of frequencies (genotype x time interaction P = <0.01; 
Bonferroni post hoc p ≤ 0.05 from 3.4-3.9Hz), the homozygous mice displayed 
significantly increased power in a broader range of frequencies from 0.48-6.3Hz 
(genotype x time interaction <0.01; Bonferroni post hoc p ≤ 0.05 from 3.4-3.9Hz), 
covering all of the delta frequency band and low end theta. Low frequency oscillations 
are associated with sleep4,82, so next we examined if the increased delta power in 
Gabra2-1 homozygous mice follows circadian patterning with respect to  
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photoentrainment. To answer this question, we next plotted cFFT’s of the 24 hour EEG 
recordings parsed with respect to the circadian time periods (Figure 2 E & F). The EEG 
recordings were made from mice entrained to a 12 hour light cycle (0700/lights on), and 
as such, subjective night (lights on) is defined as zeitgeber time (ZT) 0-12 and 
subjective day (1900/lights off) as ZT12-24. This analysis revealed the Gabra2-1 
homozygous mice had increased power in low end frequencies over the wildtype 
controls irrespective of the circadian time period (for hourly assessment of absolute  
Figure 1. Generation and characterization of the Gabra2-1 mutant mouse model basic phenotype.  
 
 
A. Cartoon depicting the large intercellular loop spanning transmembranes 3 and 4 of GABA type A 
receptor in which amino acid residues 358-375 of the α2 loop are replaced with the corresponding 
sequence from the α1 loop reducing collybistins affinity for the mutant receptor. B. Cortical extracts 
from wildtype, Gabra2-1 heterozygous, and homozygous mice were subjected to western blotting with 
antibodies raised against α2 c-terminus, collybisitin (CB), and internal control actin. C. Adult wildtype, 
Gabra2-1 heterozygous, and homozygous mice frontal cortex sections subjected to 
immunohistochemistry with antibodies raised against neurofascin to visualized the axon initial 
segment and VGAT to visualize inhibitory presynaptic markers (top overlay; bottom VGAT only)   
23 
 
 
 
 
 
 
 
 
 
Figure 2. Increased power in Gabra2-1 homozygous mice is persistent across a 24 hour period.  
 
 
A-C. Representative spectrograms (top) and raw traces (bottom) of 24 hour electroencephalographic 
(EEG) recordings made in freely moving wildtype (A), heterozygous (B), and homozygous (C) Gabra2-
1 mice. Zeitgeber time (ZT) 0-12 is the light period (0700-1900) while ZT 12-24 is the dark period 
(1900-0700) indicated by the grey bar. D. A cumulative fast Fourier transformation (cFFT) applied to 
24 hours EEG data shows increased power in Gabra2-1 homozygous (LS mean 287.789 ± 7.838)  
over wildtype (LS mean 258.869 ± 7.838) in low frequencies (LS mean het – 271.731 ± 7.011; 
genotype x frequency interaction <0.001). E & F. cFFTs of 24 hour EEG recordings parsed into ZT 0-
12 (E; LS means; WT – 245.618 ± 7.604; het – 264.703 ± 6.801; homo – 288.289 ± 7.604; genotype x 
frequency interaction <0.001) and ZT 12-24 (D; LS Means; WT – 269.787 ± 7.901; het – 278.293 ± 
7.067; homo – 289.630 ± 7.901; genotype x frequency interaction p = <0.001) suggests increased 
power in Gabra2-1 homozygous mice is maintained across subjective day and night. n = 4 to 5 per 
genotype, values listed are mean ± standard error, p values from repeated measures ANOVA, post 
hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001. 
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delta power see SI Figure 2). These observations demonstrate that Gabra2-1 
homozygous mice have persistently increased delta power across the 24 hour period. 
Collectively, these initial analyses suggested Gabra2-1 heterozygous mice have similar 
power to wildtype controls while homozygous mice have a persistent increase in delta 
that is not impacted by salient circadian cues.   
 
Electroencephalographic alterations in Gabra2-1 homozygous mice are vigilance state 
specific 
Given that we did not observe circadian specific alterations in delta power in 
Gabra2-1 mice, we next wished to examine if these alterations were vigilance state 
specific as delta frequencies are a necessary component of NR sleep83. To explore 
vigilance specificity of the EEG power alterations, we next scored each 8 second epoch 
of EEG data as corresponding to a state of wake (W), non-rapid-eye-movement sleep 
(NR), or rapid-eye-movement sleep (R) determined by the characteristics and 
relationship amongst the EEG/EMG signal for the given epoch (Materials & Methods). 
Qualitative visualization of raw traces of each vigilance state type (Figure 3 A) 
suggested Gabra2-1 animals may have altered spectral characteristics in each of these 
states. To test this observation, we plotted cFFT’s of the EEG data from 0-30Hz with 
respect to vigilance state (Figure 3 B-D). Strikingly the homozygous mice displayed 
increased power in limited yet distinct frequency ranges for each vigilance type. To 
determine the specific frequency ranges impacted, we next parsed the data into relative 
frequency bands and plotted with respect to the vigilance state (Figure 3 E-G).  
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Figure 3. Gabra2-1 homozygous mice have increased electroencephalographic power in the state of 
wake and non-rapid-eye-movement sleep restricted to specific frequency ranges.  
 
 
A. 4 second representative electroencephalographic (EEG) and electromyographic traces from 
wildtype, heterozygous, and homozygous Gabra2-1 mice scored as a state of wake (W), non-rapid-
eye-movement sleep (NR), or rapid-eye-movement sleep (R). B-D. Cumulative fast Fourier 
transformation (cFFT) of 24 hours EEG data parsed with respect to vigilance state reveals the power 
structure of epochs scored as W (B; LS means; WT – 214.339 ± 10.684; het – 243.179 ± 9.556; 
homo – 254.766 ± 10.684; genotype x frequency interaction p <0.001), NR (C; LS means; WT – 
287.847 ± 5.098; het – 291.478 ± 4.560; homo 306.632 ± 5.098; genotype x frequency interaction P 
<0.001), or R (D; LS means; WT – 234.160 ± 10.084; het – 242.182 ± 9.020; homo – 263.739 ± 
10.084; genotype x frequency interaction p = 0.007). E-G. Spectral analysis of EEG data parsed 
with respect to vigilance state for a 24 hour period demonstrates Gabra2–1 homozygous mice have 
increased δ power (0.4-5Hz) restricted to the state of NR (E; LS means; WT – 550.896 ± 52.403; het 
– 592.037 ± 46.871; homo – 696.291 ± 52.403) and decreased γ power restricted to the state of W 
(G; WT – 29.580 ± 3.671; het – 24.656 ±3.283; homo 17.291 ± 3.671) while other relevant frequency 
bands including theta (F; WT – 417.148 ± 2.899; het – 428.276 ± 18.692; homo – 504.932 ±20.899) 
are non-significant when compared to controls (for normalization variations see supplemental figure 
3). n = 4 to 5 per genotype, values listed are mean ± standard error, p values from repeated 
measures ANOVA, post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001. 
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Frequency band ranges in this study are defined as follows: delta (0.5-4 Hz), theta (4-12  
Hz), alpha (12-18 Hz), beta 18-30 Hz), and gamma (30-100 Hz). This analysis allowed 
us to discover that the Gabra2-1 homozygous mice had increased power in the delta 
frequency ranges restricted to the state of NR (Figure 3 E) accompanied by a by a 
decrease in gamma power restricted to periods of W (Figure 3 G; for spectral analysis 
of vigilance states when normalized to all band variations see SI Figure 3). More 
broadly, these findings suggest that Gabra2-1 homozygous mice have altered EEG 
power during both wake and sleep, but that these alterations are restricted to specific 
frequencies. 
 
Gabra2-1 mice spend more time awake during the subjective night 
In light of the observation that Gabra2-1 homozygous mice had increased delta 
power restricted to the state of NR we hypothesized that they would have altered 
structural organization of sleep, or sleep architecture. To test this hypothesis, we 
individually housed diurnally entrained mice in metabolic activity chambers in which 
activity is chronically measured by beam break. Over the course of 14 days we 
observed an increase in Gabra2-1 homozygous activity during ZT 0-12 (Figure 4 A-B). 
In addition, we observed a sharp increase in activity one-hour post and prior to the 
day/night transition (Figure 4 C). Activity can act as a proxy for wakefulness thus these 
data suggests Gabra2-1 homozygous mice have increased time awake during ZT 0-12 
(subjective night). Activity based assessment is limited by the fact that it cannot detect 
subtle vigilance states such as quiet wakefulness, when the mouse is awake but not 
moving. To mitigate this confound we next examined EEG records, the ‘gold standard’ 
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for determining ongoing vigilance99. Subsequent examination of data scored for 
vigilance (Materials & Methods) reveled the percent time animals spent in each  
 
 
 
 
Figure 4. Gabra2-1 homozygous spend more time 
awake during subjective night. 
 
 
 A. 24 hour plot representing 14 days activity from 
diurnally entrained wildtype, and homozygous 
Gabra2-1 mice individually housed in metabolic 
activity chambers under diurnal conditions. B. 
Assessment of total activity during zeitgeber time 
(ZT) 0-12 (subjective night). C. Assessment of total 
activity during ZT 1 and ZT 24. D & E. Analysis of 
percent (%) time spent in a state of wake (W) (D; LS 
means; WT – 51.281 ± 1.760; het – 48.419 ± 1.574; 
homo – 53.747 ± 1.760), or rapid-eye-movement 
sleep (R) (E; LS means; WT – 4.886 ± 0.283; het – 
4.470 ± 0.253; homo – 3.923 ± 0.283) over 24 
hours, ZT 0-12, or ZT 12-24 demonstrates Gabra2-
1 homozygous mice spend more time awake during 
subjective night (NR represented in supplemental 
figure 4). F. Ratio of theta/delta power binned every 
15 minutes to examine regulation of frequency 
bands associated with vigilance state transitions (LS 
means; WT – 0.853 ± 0.0690; het – 0.824 ± 0.0617; 
homo – 1.061 ± 0.0691; genotype x frequency 
interaction p = 0.012). n = 4 to 5 per genotype, 
values listed are mean ± standard error, p values 
from one way ANOVA or repeated measures 
ANOVA, post hoc Bonferroni, * = ≤0.05, ** = ≤
0.005, *** = <0.001. 
 
 * 
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vigilance state across ZT 0-12 and ZT 12-24 (Figure 4 D & E) is altered, again suggest 
disrupted sleep architecture in Gabra2-1 homozygous mice. Specifically, the EEG 
assessment revealed Gabra2-1 heterozygous and homozygous mice spend similar 
amounts of time in each vigilance state across the 24 hour period, yet the homozygous 
mice spend significantly more time awake during subjective night (Figure 4 D ZT 0-12) 
at the expense of time in R (Figure 4 E ZT 0-12). Further, this observation is restricted 
to subjective night as Gabra2-1 animals spend similar time in each vigilance state 
during subjective day (Figure 4 D & F; ZT 12-24; NR represented in SI figure 4).  
Driven by our observations that Gabra2-1 homozygous mice have reduced sleep 
restricted to subjective night we next wished to examine biological indicators of 
appropriate vigilance regulation. While prominent delta power is associated with NR 
sleep, high theta frequencies are associated with wake and transitioning amongst these 
states82,85. To understand the ongoing relationship amongst these signals modulating 
vigilance and transitioning in the mice, we next plotted a ratio of theta to delta 
frequencies when binned every 15 minutes over a 24 hour period (Figure 4 F). This 
analysis suggested that Gabra2-1 homozygous mice do not regulate the relationship 
amongst these behaviorally relevant frequency ranges in the same way as the wildtype 
littermates, with aberration appearing around the transition from subjective day to night 
(Figure 4 F). To confirm these findings are not an artifact of an inability to detect 
photoperiods due to visual impairment, two visual placement task from the modified 
SHIRPA screening protocols (http://empress.har.mrc.ac.uk/browse/?sop_id = 10_002_0) 
were preformed (Materials & Methods) demonstrating normal vision in both 
heterozygous and homozygous Gabra2-1 mice (SI table 1). These findings suggest 
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Gabra2-1 homozygous mice have altered sleep architecture during subjective night that 
may be driven by dysregulation of global brain states. 
 Gabra2-1 have deficits in vigilance state transitions restricted to subjective night 
Encouraged by our observations of decreased time asleep during subjective 
night and deficits in regulation of brain states associated with vigilance state 
transitioning in Gabra2-1 homozygous mice, we next wished to examine vigilance state 
duration and transitions across a 24 hour period. These measures are indicators of 
sleep quality as they are disrupted when the suprachiasmatic nuclei is lesioned86 or 
when animals are housed under continuous bright light87. Qualitative examination of 24 
hour actograms (Figure 5 A) suggested altered vigilance state bout duration (time 
between transitions) and total transitions (vigilance shift from W to NR, NR to W, NR to 
R, or R to NR.) To quantitatively assess this observation, we determined the mean bout 
duration of W, NR, and R with respect to subjective day and night (Figure 5 B & C). 
These data show a striking increase in mean bout duration of W in Gabra2-1 
homozygous mice during subjective night (Figure 5 B) which is not present during 
subjective day (Figure 5 C). To corroborate these data we next plotted the total number 
of transitions occurring over 24 hours (SI Figure 4), and within ZT 0-12 and ZT 12-24 
(Figure 5 D & E) as we would expect decreased transitions to accompany an increase 
in mean bout duration. These data show Gabra2-1 homozygous mice have decreased 
total transitions over 24 hours (SI Figure 4), yet these deficits are restricted to subjective 
night (Figure 5 D & E). To further clarify the microarchitecture of the observed deficits in 
transitioning during the light phase we next examined the number of transitions 
occurring during ZT 0-12 and ZT 12-24 by transition type (Figure 5 F & G). This analysis  
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Figure 5. Gabra2-1 homozygous have increased vigilance state duration and decreased transitions 
restricted to subjective night.  
 
 
A. Representative hypnograms of 24 hour electroencephalographic (EEG) recordings parsed into 8 
second epochs and scored as a state of wake (W), non-rapid-eye-movement sleep (NR), or rapid-eye-
movement sleep (R) from wildtype, heterozygous, and homozygous Gabra2-1 mice. B & C. Mean 
duration of vigilance state bout scored as W, NR, or R for zeitgeber time (ZT) 0-12 (B; LS means; WT 
– 360.333 ± 40.046; het – 429.800 ± 35.818; homo – 524.333 ±40.046) and ZT 12-24 (C; LS means 
WT – 769.167 ± 170.414; het 828.867 ± 152.423; homo 832.583 ± 170.414). D & E. Summation of all 
vigilance state transition types for ZT 0-12 (D; LS means; WT – 202.000 ± 10.840; het – 171.600 ± 
4.366; homo – 155.500 ± 10.82) and ZT 12-24 (E; LS means; WT – 63.000 ± 7.141; het 57.400 ± 
3.868; homo – 61.250 ± 11.643) shows an overall deficit in Gabra2-1 homozygous mice transitions 
during the light phase. F & G. Examination of transitions by type during ZT 12-0 (F; LS means; WT – 
34.750 ± 3.705; het – 33.920 ± 3.314; homo 23.563 ± 3.705) and ZT 12-24 (G; LS means; WT – 
15.750 ± 1.991; het – 14.350 ± 1.781; homo – 15.313 ± 1.991). n = 4 to 5 per genotype, values listed 
are mean ± standard error, p values from one way ANOVA or repeated measures ANOVA, post hoc 
Bonferroni, * = ≤0.05, ** = ≤0.005, *** = <0.001. 
 
31 
 
supported our findings that transitioning is reduced during subjective night and revealed 
that this reduction is specific to the transition into and out of R (Figure 5 F). Taken  
together, our findings demonstrate that the Gabra2-1 homozygous mice have reduced 
time asleep during subjective night that is manifested as a reduction in behavioral 
transitions during sleep, specifically when transitioning into and out of NR sleep.  
 
Gabra2-1 mice cannot maintain free running circadian rhythmicity and have attenuated 
response to sleep deprivation. 
Next, we undertook two experiments, each introducing a sleep challenge, to 
determine the homeostatic sleep response of Gabra2-1 mice. In the first experiment we 
individually housed diurnally entrained mice in metabolic activity chambers allowing for 
the chronic tracking of movement by beam break. Initially baseline activity was 
monitored under diurnal conditions (L/D; Figure 6 A top actograms) for 14 days followed 
by the introduction of constant darkness (D/D; Figure 6 A bottom actograms) for 14 
days. Qualitative assessment suggests the wildtype group maintained a free running 
circadian rhythm for the entirety of the D/D portion of the experiment88 while the 
Gabra2-1 homozygous mice displayed an aberrant increase in activity on the first light 
period in which darkness was introduced (Figure 6 A bottom right actogram). A 
quantitative comparison of total activity during subjective night under L/D and D/D 
conditions (Figure 6 B) demonstrated the loss of light, the most salient environmental 
zeitgeber, causes a significant increase in activity in Gabra2-1 homozygous mice during  
ZT 0-12. Encouraged by our findings that Gabra2-1 homozygous mice are unable to 
maintain a free running circadian rhythm in the absence of light, we next set out to 
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examine how these animals would respond to a severe sleep challenge such as total 
sleep deprivation (SD). To determine the homeostatic response to sleep loss, we 
recorded EEG while inducing SD by gentile handling methods for a total of 24 hours 
(Materials & Methods; timeline Figure 6 C; representative spectrograms Figure 6 D). On 
the day of 24 hours sleep deprivation Gabra2-1 mice had a similar response to the 
procedures as the wildtype group, maintaining a state of W for ~95% of the time (Figure 
6 E), yet had a very different homeostatic response on the recovery day. Analysis of  
percent time pre/post sleep deprivation reveal an expected decrease in time spent 
awake in the wildtype group which is compensated for by an increase in time spent in 
the stage of NR and R (Figure F G; pre/post SD x vigilance state interaction p = 0.002) 
while both Gabra2-1 heterozygous and homozygous show no significant changes 
(Figure 6 G & H). Taken together these findings demonstrate Gabra2-1 homozygous 
mice have an inability to homeostatically respond to sleep challenges.  
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Figure 6. Gabra2-1 homozygous mice have altered behavioral response to sleep challenges. 
 
 
A. Representative actograms of 24 hours activity under diurnal (L/D; top trace) and total darkness 
conditions (D/D; bottom trace) from wildtype (left) and Gabra2-1 homozygous (right) mice. B. 
Comparison of total activity under diurnal conditions (grey bars) and constant darkness. C. 
Comparison of activity ratio under diurnal conditions (grey bars) and constant darkness. D. Sleep 
deprivation (SD) timeline. E. Representative wildtype spectrograms from each day of SD experiment. 
F. Quantification of percent time spent in a state of wake (W) or non-rapid-eye-movement sleep (NR) 
representing 24 hours of SD. G-I. Quantification of percent time spend in a state of W, NR, or rapid-
eye-movement sleep (R) pre and post SD for wildtype (G; LS means; W – 52.383 ± 3.893; NR – 
42.800 ± 3.893; R – 4.788 ± 3.893), heterozygous (H; LS means; W 57.879 ± 3.578; NR – 37.500 ± 
3.578; R – 4.621 ± 3.578), and Gabra2-1 homozygous mice (I; LS means; W – 51.112 ± 1.817; NR – 
44.613 ± 1.817; R – 4.272 ± 1.817). SD data n = 2 per genotype; values listed are mean ± standard 
error; p values from repeated measures ANOVA, post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = 
<0.001. 
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CHAPTER 6 
                                 DISSCUSSION AND FUTURE DIRECTIONS 
          Despite the significant role of GABAARs containing the α2 subunit found at the 
AIS at controlling excitatory output, little is known about the behavioral impact of its loss. 
Here we report reduced α2 signaling at the AIS results in a drastic increase in baseline 
EEG delta power in Gabra2-1 homozygous mice. This finding extends previous 
observations of increased delta power in Gabra2-1 homozygous mice to a longer time 
scale (24 hours) as previous recordings were 1hr in duration and made while the 
animals were awake. In addition, by utilizing longer recording times we were able to 
discover that the increase in baseline delta power is not modulated with respect to the 
animal’s circadian period. These findings suggest Gabra2-1 homozygous mice have 
altered brain wide processing. 
Given the Gabra2-1 mouse model displayed an increase in delta frequencies 
which are predominate during the state of NR sleep, we next wished to parse out the 
specific impact of loss of α2 signaling at the AIS on sleep and sleep quality. 
Examination of 24 hour EEG recordings revealed the increased delta power observed in 
Gabra2-1 homozygous mice is restricted to the state of NR sleep while decreased 
gamma power is observed during the state of W. Although further measures are needed 
to determine the behavioral impact of reduced gamma power in Gabra2-1 homozygous 
mice during W, gamma power is associated with active learning and memory7,89. 
Further, altered gamma frequencies are often observed in psychiatric disorders and 
neurodevelopmental disorders90–92. In addition, high frequencies (30-100Hz) have been 
demonstrated to be dependent upon the activity of GABAARs found at inhibitory 
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synaptic sites93. Given this, our observation of the Gabra2-1 mouse model suggests 
gamma frequencies during the state of W may depend upon α2 signaling at the AIS. 
Delta power is modulated by prior activity with extended wakefulness resulting in 
increased delta power71. As such, high delta during NR sleep is associated with high 
levels of sleep pressure69. Our data demonstrate Gabra2-1 homozygous mice have 
increased delta power restricted to the state of NR indicating they have a high level of 
baseline sleep pressure. Interestingly, high sleep pressure (delta) does not correlate to 
good sleep quality as people with Rett’s syndrome, who demonstrate continuous high 
delta activity, have been shown to have poor sleep efficiency94. 
Because we detected several baseline measures altered that are associated with 
sleep and sleep quality, we next examined the distribution of vigilance in the Gabra2-1 
mice across an entire circadian cycle. We observed a similar amount of time spend in a 
state of W, NR, or R when examining the 24 hour period, yet when parsed by subjective 
day and night we find altered distribution of these states. Specifically, we find an 
increase in time spend awake during subjective night. Further, we found dysregulation 
amongst the relationship between delta and theta frequencies occurring primarily 2 
hours before and after the day/night transition. Data from the human population 
suggests sleep onset is depended on the reduction of high frequency’s associated with 
wakefulness (beta, alpha, gamma) and an increase in the low frequencies associated 
with sleep (delta and theta)95. Therefore, the dysregulation of delta to theta observed in 
Gabra2-1 homozygous may be mechanistic in our findings that they have difficulty 
patterning vigilance around the circadian cycle. These data suggest the observed 
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baseline EEG alterations have a significant impact on the homeostatic progression of 
sleep in Gabra2-1 mice.  
Having established an increase in time spent awake during subjective night along 
with an indication of poor regulation of vigilance state transitions (dysregulated 
delta/theta) in Gabra2-1 homozygous mice, we next set out to examine vigilance state 
transitions across the 24 hour period. When examining all vigilance state transition 
types (W to NR, NR to W, NR to R, and NR to R) we report an overall deficit in vigilance 
state transitioning in Gabra2-1 homozygous mice that is restricted to subjective night. 
Further, when parsed by transition type, we find the deficit in transitioning is restricted to 
the transitions from NR sleep into R sleep or from R sleep back into NR sleep (NR-R-
NR). The NR-R-NR transitions are a relatively well described process that depend on 
inhibition or disinhibition at appropriate times of several brain regions including the 
pontine nuclei96,97. Of note, the pontine nuclei is found to be highly enriched with α220. In 
addition, in humans it has been demonstrated that the onset of REM sleep is preceded 
by a decrease in delta and theta power and the inverse is true for its offset98. Our data 
suggests reduced α2 at the AIS increases baseline delta power, altering the relationship 
amongst the delta and theta frequencies and as such may contribute to the observed 
difficulty in the NR-R-NR transition.  
Having established baseline alterations in Gabra2-1 homozygous EEG activity, 
vigilance state patterning, and vigilance state transitioning, we set out to confirm these 
observations by introducing sleep challenges. It is well known that some sleep disorders 
are associated with difficulty maintaining circadian rhythmicity and coping with 
challenges to sleep99,100. Thus, if the Gabra2-1 mice are having difficulty with sleep 
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patterning, we would expect to see an altered homeostatic response to sleep 
challenges. Here we report a deficit in Gabra2-1 homozygous mice ability to maintain a 
circadian rhythm in the absences of the salient environmental zeitgeber light. This deficit 
may be considered severe as we observed a loss of rhythmicity in a brief period of time 
(1 to 2 days of constant darkness) while the wildtype mice maintained a free running 
rhythm for the entirety of the experiment. Further supporting our findings of sleep 
deficits in Gabra2-1 homozygous mice, here we report an attenuated homoeostatic 
response to SD. As mentioned above, it is a well-known phenomenon that sleep 
pressure is dependent upon prior activity thus, SD increases sleep pressure69,71. Given 
Gabra2-1 homozygous mice underwent SD similar to wildtype controls (~95% W of 24 
hours SD) it is striking to report an inability of these mice to homeostatically alter 
vigilance state patterning (increase time asleep) as little to no change occurred in 
response to SD. These data taken together demonstrate the Gabra2-1 homozygous 
mice have difficulty homeostatically responding to sleep challenges and support our 
claims of baseline homeostatic dysregulation.  
In conclusion, our findings reveal the role of GABAA receptors containing the α2 
subunit found enriched at the AIS postsynaptic to chandelier cells to the establishment, 
maintenance, and quality of sleep. We demonstrate that a loss of GABAergic signaling 
at the AIS results in an overall increase in EEG delta frequencies that are maintained 
across the circadian cycle. We find this increase in delta power is accompanied by 
alterations to vigilance state patterning, specifically, a reduction in time asleep during 
subjective night. Lastly, we report an altered response to two different sleep challenges 
in Gabra2-1 mice, supporting our findings of poor-quality baseline sleep. These data 
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begin to shed light on the molecular mechanisms of common sleep disturbances 
observed in humans known to have altered GABAergic. Further these data will provide 
insight for the development of targeted sleep therapeutics.  
 To conclude this project, we are currently undertaking experiments using IHC to 
examine GABAARs containing the α2 subunit in the tuberomammillary nucleus of 
Gabra2-1 mice. The tuberomammillary nucleus houses histaminergic neurons that are 
active during W and inactive during states of sleep. GABAergic neurons projecting from 
the preoptic nucleus drive this sleep wake profile of histaminergic neurons. We suspect 
a reduction of α2 receptors in the tuberomammillary nucleus may be mechanistic to the 
homeostatic dysregulation of sleep observed in Gabra2-1 mice.  
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CHAPTER 7 
SUPPLEMENTARY INFORMATION 
 
 
 
 
 
 
 
Supplementary Figure 1. Generation and genotyping Gabra2-1 mice.  
 
 
A. Cartoon schematic depicting the targeting vector used to insert amino acid residues 358-375 form 
the large intercellular α1 loop into exon 10 of the α2 subunit. B. Representative polymerase change 
reaction results for identification of wildtype littermate controls, Gabra2-1 heterozygous (het), and 
Gabra2-1 homozygous (homo) mice.  
Supplementary Figure 2. Hourly assessment of absolute delta power for a 24 hour period.  
 
 
Summation of total power in frequencies from 0.5-4Hz hrouly for 24 hours suggests consistently 
elevated power in Gabra2-1 homozygous mice across the circadian cycle (LS means; WT – 
121571.135 ± 48565.020; het – 166484.957 ± 43437.874; homo – 287123.257 ± 48565.020) n = 4 to 
5 per genotype; values listed are mean ± standard error; p values from repeated measures ANOVA, 
post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001. 
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Supplemental Figure 3. 24 hour cFFT normalized to delta, theta, and gamma.  
 
 
A-C. Cumulative fast fourier transformation (cFFT) applied to 24 hours EEG data and normalized to 
average δ power for 24 hour period (A), Zeitgeber time (ZT) 0-12 (B), and ZT 12-24 (C). D-F. 
Cumulative fast Fourier transformation (cFFT) applied to 24 hours EEG data and normalized to 
average θ power for 24 hour period (D), ZT 0-12 (E), and ZT 12-24 (F). G-I. Cumulative fast Fourier 
transformation (cFFT) applied to 24 hours EEG data and normalized to average γ power for 24 hour 
period (G), ZT 0-12 (H), and ZT 12-24 (I).  
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Supplementary Figure 4. Assessment of percent time spent in state of non-rapid-eye-movement 
sleep.  
 
 
Values expressed as a percent of total analysis time (24 hours, zeitgeber time (ZT) 0-12, and ZT 12-
24). n = 4 to 5 per genotype; values listed are mean ± standard error; p values from repeated 
measures ANOVA, post hoc Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001. 
 
Supplementary Figure 5. Assessment of total transitions across a 24 hour period.  
 
 
Summation of all transition types (W to NR, NR to W, NR to R, and R to NR) across a 24 hour period 
demonstrates a significant reduction in Gabra2-1 homozygous mice vigilance state transitioning. n = 4 
to 5 per genotype; values listed are mean ± standard error; p values from one way ANOVA, post hoc 
Bonferroni; * = ≤0.05, ** = ≤0.005, *** = <0.001. 
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Supplementary Table 1. Results for two visual tests from modified SHIRPA screening protocols.   
 
43 
 
BIBLIOGRAPHY 
1. Benington, J. H. Sleep homeostasis and the function of sleep. Sleep 23, 959–966 
(2000). 
2. Colten, H. R., Altevogt, B. M. & Research, I. of M. (US) C. on S. M. and. Extent and 
Health Consequences of Chronic Sleep Loss and Sleep Disorders. (National 
Academies Press (US), 2006). 
3. Ju, Y.-E. S., Videnovic, A. & Vaughn, B. V. Comorbid Sleep Disturbances in 
Neurologic Disorders. Contin. Minneap. Minn 23, 1117–1131 (2017). 
4. Borbély, A. A. A two process model of sleep regulation. Hum. Neurobiol. 1, 195–
204 (1982). 
5. Takahashi, J. S., Hong, H.-K., Ko, C. H. & McDearmon, E. L. The genetics of 
mammalian circadian order and disorder: implications for physiology and disease. 
Nat. Rev. Genet. 9, 764–775 (2008). 
6. Kleitman, N. Basic rest-activity cycle--22 years later. Sleep 5, 311–317 (1982). 
7. Sejnowski, T. J. & Destexhe, A. Why do we sleep? Brain Res. 886, 208–223 
(2000). 
8. Montgomery, S. M., Sirota, A. & Buzsáki, G. Theta and gamma coordination of 
hippocampal networks during waking and REM sleep. J. Neurosci. Off. J. Soc. 
Neurosci. 28, 6731–6741 (2008). 
9. Chung, S. et al. Identification of preoptic sleep neurons using retrograde labelling 
and gene profiling. Nature 545, 477–481 (2017). 
10. Wisden, W., Yu, X. & Franks, N. P. GABA Receptors and the Pharmacology of 
Sleep. 1–26 (2017). doi:10.1007/164_2017_56 
11. Möhler, H., Crestani, F. & Rudolph, U. GABAA-receptor subtypes: a new 
pharmacology. Curr. Opin. Pharmacol. 1, 22–25 (2001). 
12. Rudolph, U. et al. Benzodiazepine actions mediated by specific gamma-
aminobutyric acid(A) receptor subtypes. Nature 401, 796–800 (1999). 
13. Scammell, T. E., Arrigoni, E. & Lipton, J. Neural Circuitry of Wakefulness and 
Sleep. Neuron 93, 747–765 (2017). 
14. Sieghart, W. & Sperk, G. Subunit composition, distribution and function of GABA(A) 
receptor subtypes. Curr. Top. Med. Chem. 2, 795–816 (2002). 
15. Ali Rodriguez, R., Joya, C. & Hines, R. M. Common Ribs of Inhibitory Synaptic 
Dysfunction in the Umbrella of Neurodevelopmental Disorders. Front. Mol. 
Neurosci. 11, (2018). 
16. Preserving the balance: diverse forms of long-term GABAergic synaptic plasticity | 
Nature Reviews Neuroscience. (2019). Available at: 
https://www.nature.com/articles/s41583-019-0141-5. (Accessed: 9th April 2019) 
17. Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E. & McCarley, R. W. 
CONTROL OF SLEEP AND WAKEFULNESS. Physiol. Rev. 92, 1087–1187 
(2012). 
18. Gottesmann, C. GABA mechanisms and sleep. Neuroscience 111, 231–239 
(2002). 
19. Clark, B. D., Goldberg, E. M. & Rudy, B. Electrogenic Tuning of the Axon Initial 
Segment. Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry 15, 651–668 
(2009). 
44 
 
20. Mozrzymas, J. W., Zarnowska, E. D., Pytel, M., Mercik, K. & Zarmowska, E. D. 
Modulation of GABA(A) receptors by hydrogen ions reveals synaptic GABA 
transient and a crucial role of the desensitization process. J. Neurosci. Off. J. Soc. 
Neurosci. 23, 7981–7992 (2003). 
21. Tretter, V., Ehya, N., Fuchs, K. & Sieghart, W. Stoichiometry and Assembly of a 
Recombinant GABAA Receptor Subtype. J. Neurosci. 17, 2728–2737 (1997). 
22. Klausberger, T., Roberts, J. D. B. & Somogyi, P. Cell Type- and Input-Specific 
Differences in the Number and Subtypes of Synaptic GABAA Receptors in the 
Hippocampus. J. Neurosci. 22, 2513–2521 (2002). 
23. Klausberger, T. & Somogyi, P. Neuronal Diversity and Temporal Dynamics: The 
Unity of Hippocampal Circuit Operations. Science 321, 53–57 (2008). 
24. Leterrier, C. The Axon Initial Segment: An Updated Viewpoint. J. Neurosci. Off. J. 
Soc. Neurosci. 38, 2135–2145 (2018). 
25. Nusser, Z., Sieghart, W., Benke, D., Fritschy, J. M. & Somogyi, P. Differential 
synaptic localization of two major gamma-aminobutyric acid type A receptor alpha 
subunits on hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U. S. A. 93, 
11939–11944 (1996). 
26. Somogyi, P., Tamás, G., Lujan, R. & Buhl, E. H. Salient features of synaptic 
organisation in the cerebral cortex. Brain Res. Brain Res. Rev. 26, 113–135 (1998). 
27. Grubb, M. S. et al. Short- and long-term plasticity at the axon initial segment. J. 
Neurosci. Off. J. Soc. Neurosci. 31, 16049–16055 (2011). 
28. Rowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R. & Dawson, G. R. Different 
GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects 
of benzodiazepine-like drugs in primates. Proc. Natl. Acad. Sci. U. S. A. 102, 915–
920 (2005). 
29. Kopp, C., Rudolph, U. & Tobler, I. Sleep EEG changes after zolpidem in mice. 
Neuroreport 15, 2299–2302 (2004). 
30. Uygun, D. S. et al. Bottom-Up versus Top-Down Induction of Sleep by Zolpidem 
Acting on Histaminergic and Neocortex Neurons. J. Neurosci. Off. J. Soc. 
Neurosci. 36, 11171–11184 (2016). 
31. Bäckberg, M., Ultenius, C., Fritschy, J.-M. & Meister, B. Cellular localization of 
GABA receptor alpha subunit immunoreactivity in the rat hypothalamus: 
relationship with neurones containing orexigenic or anorexigenic peptides. J. 
Neuroendocrinol. 16, 589–604 (2004). 
32. Fritschy, J. M. & Mohler, H. GABAA-receptor heterogeneity in the adult rat brain: 
differential regional and cellular distribution of seven major subunits. J. Comp. 
Neurol. 359, 154–194 (1995). 
33. Sergeeva, O. A., Andreeva, N., Garret, M., Scherer, A. & Haas, H. L. 
Pharmacological properties of GABAA receptors in rat hypothalamic neurons 
expressing the epsilon-subunit. J. Neurosci. Off. J. Soc. Neurosci. 25, 88–95 
(2005). 
34. Tretter, V. et al. Deficits in spatial memory correlate with modified γ-aminobutyric 
acid type A receptor tyrosine phosphorylation in the hippocampus. Proc. Natl. 
Acad. Sci. 106, 20039–20044 (2009). 
35. Hines, R. M. et al. Developmental seizures and mortality result from reducing 
GABAA receptor α2-subunit interaction with collybistin. Nat. Commun. 9, (2018). 
45 
 
36. Bowery, N. G. & Smart, T. G. GABA and glycine as neurotransmitters: a brief 
history. Br. J. Pharmacol. 147, S109–S119 (2006). 
37. Erlander, M. G., Tillakaratne, N. J., Feldblum, S., Patel, N. & Tobin, A. J. Two 
genes encode distinct glutamate decarboxylases. Neuron 7, 91–100 (1991). 
38. Trist, D. G., Kenakin, T. P. & Blackburn, T. P. In memory of Norman Bowery (1944-
2016). Curr. Opin. Pharmacol. 35, 89–93 (2017). 
39. Benarroch, E. E. GABAB receptors: structure, functions, and clinical implications. 
Neurology 78, 578–584 (2012). 
40. Tiao, J. Y.-H. & Bettler, B. Characteristics of GABA<Subscript>B</Subscript> 
Receptor Mutant Mice. in The GABA Receptors 273–287 (Humana Press, 2007). 
doi:10.1007/978-1-59745-465-0_11 
41. Sieghart, W. Structure and pharmacology of gamma-aminobutyric acidA receptor 
subtypes. Pharmacol. Rev. 47, 181–234 (1995). 
42. Sieghart, W. & Sperk, G. Subunit composition, distribution and function of GABA(A) 
receptor subtypes. Curr. Top. Med. Chem. 2, 795–816 (2002). 
43. Kole, M. H. P. & Stuart, G. J. Signal processing in the axon initial segment. Neuron 
73, 235–247 (2012). 
44. Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J. & Wafford, K. A. 
Pharmacological characterization of a novel cell line expressing human α4β3δ 
GABAA receptors. Br. J. Pharmacol. 136, 965–974 (2002). 
45. Haas, K. F. & Macdonald, R. L. GABAA receptor subunit gamma2 and delta 
subtypes confer unique kinetic properties on recombinant GABAA receptor 
currents in mouse fibroblasts. J. Physiol. 514 ( Pt 1), 27–45 (1999). 
46. Lewis, D. A., Hashimoto, T. & Volk, D. W. Cortical inhibitory neurons and 
schizophrenia. Nat. Rev. Neurosci. 6, 312–324 (2005). 
47. Kneussel, M. et al. Loss of postsynaptic GABA(A) receptor clustering in gephyrin-
deficient mice. J. Neurosci. Off. J. Soc. Neurosci. 19, 9289–9297 (1999). 
48. Kneussel, M. et al. The gamma-aminobutyric acid type A receptor (GABAAR)-
associated protein GABARAP interacts with gephyrin but is not involved in receptor 
anchoring at the synapse. Proc. Natl. Acad. Sci. U. S. A. 97, 8594–8599 (2000). 
49. Mukherjee, J. et al. The residence time of GABA(A)Rs at inhibitory synapses is 
determined by direct binding of the receptor α1 subunit to gephyrin. J. Neurosci. 
Off. J. Soc. Neurosci. 31, 14677–14687 (2011). 
50. Tretter, V. et al. The clustering of GABA(A) receptor subtypes at inhibitory 
synapses is facilitated via the direct binding of receptor alpha 2 subunits to 
gephyrin. J. Neurosci. Off. J. Soc. Neurosci. 28, 1356–1365 (2008). 
51. Tretter, V. et al. Molecular basis of the γ-aminobutyric acid A receptor α3 subunit 
interaction with the clustering protein gephyrin. J. Biol. Chem. 286, 37702–37711 
(2011). 
52. Cajal, S. R. et al. Estructura de los centros nerviosos de las aves. (1888). 
53. Yuste, R. From the neuron doctrine to neural networks. Nat. Rev. Neurosci. 16, 
487–497 (2015). 
54. Hodgkin, A. L. & Huxley, A. F. A quantitative description of membrane current and 
its application to conduction and excitation in nerve. J. Physiol. 117, 500–544 
(1952). 
46 
 
55. Van Wart, A., Trimmer, J. S. & Matthews, G. Polarized distribution of ion channels 
within microdomains of the axon initial segment. J. Comp. Neurol. 500, 339–352 
(2007). 
56. Lorincz, A. & Nusser, Z. Cell-Type-Dependent Molecular Composition of the Axon 
Initial Segment. J. Neurosci. 28, 14329–14340 (2008). 
57. Royeck, M. et al. Role of axonal NaV1.6 sodium channels in action potential 
initiation of CA1 pyramidal neurons. J. Neurophysiol. 100, 2361–2380 (2008). 
58. Dodson, P. D., Barker, M. C. & Forsythe, I. D. Two heteromeric Kv1 potassium 
channels differentially regulate action potential firing. J. Neurosci. Off. J. Soc. 
Neurosci. 22, 6953–6961 (2002). 
59. Somogyi, P. A specific ‘axo-axonal’ interneuron in the visual cortex of the rat. Brain 
Res. 136, 345–350 (1977). 
60. Tai, Y., Gallo, N. B., Wang, M., Yu, J.-R. & Van Aelst, L. Axo-axonic Innervation of 
Neocortical Pyramidal Neurons by GABAergic Chandelier Cells Requires 
AnkyrinG-Associated L1CAM. Neuron (2019). doi:10.1016/j.neuron.2019.02.009 
61. Tai, Y., Janas, J. A., Wang, C.-L. & Van Aelst, L. Regulation of chandelier cell 
cartridge and bouton development via DOCK7-mediated ErbB4 activation. Cell 
Rep. 6, 254–263 (2014). 
62. Inan, M. et al. Dense and overlapping innervation of pyramidal neurons by 
neocortical chandelier cells. J. Neurosci. Off. J. Soc. Neurosci. 33, 1907–1914 
(2013). 
63. Ribak, C. E. Axon terminals of GABAergic chandelier cells are lost at epileptic foci. 
Brain Res. 326, 251–260 (1985). 
64. Rubenstein, J. L. R. & Merzenich, M. M. Model of autism: increased ratio of 
excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255–267 (2003). 
65. Ariza, J., Rogers, H., Hashemi, E., Noctor, S. C. & Martínez-Cerdeño, V. The 
Number of Chandelier and Basket Cells Are Differentially Decreased in Prefrontal 
Cortex in Autism. Cereb. Cortex N. Y. N 1991 28, 411–420 (2018). 
66. Volk, D. W. et al. Reciprocal alterations in pre- and postsynaptic inhibitory markers 
at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex N. Y. 
N 1991 12, 1063–1070 (2002). 
67. Massi, L. et al. Temporal Dynamics of Parvalbumin-Expressing Axo-axonic and 
Basket Cells in the Rat Medial Prefrontal Cortex In Vivo. J. Neurosci. Off. J. Soc. 
Neurosci. 32, 16496–16502 (2012). 
68. Aschoff, J. Circadian Rhythms in Man: A self-sustained oscillator with an inherent 
frequency underlies human 24-hour periodicity. Science 148, 1427–1432 (1965). 
69. McKenna, J. T. et al. Sleep fragmentation elevates behavioral, electrographic and 
neurochemical measures of sleepiness. Neuroscience 146, 1462–1473 (2007). 
70. Rodriguez, A. V. et al. Why Does Sleep Slow-Wave Activity Increase After 
Extended Wake? Assessing the Effects of Increased Cortical Firing During Wake 
and Sleep. J. Neurosci. Off. J. Soc. Neurosci. 36, 12436–12447 (2016). 
71. Suzuki, A., Sinton, C. M., Greene, R. W. & Yanagisawa, M. Behavioral and 
biochemical dissociation of arousal and homeostatic sleep need influenced by prior 
wakeful experience in mice. Proc. Natl. Acad. Sci. U. S. A. 110, 10288–10293 
(2013). 
47 
 
72. Mazuski, C. et al. Entrainment of Circadian Rhythms Depends on Firing Rates and 
Neuropeptide Release of VIP SCN Neurons. Neuron 99, 555-563.e5 (2018). 
73. Kräuchi, K. & Wirz-Justice, A. Circadian clues to sleep onset mechanisms. 
Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 25, S92-96 
(2001). 
74. Kleitman, N. Sleep and wakefulness. (Univ. Chicago Press, 1963). 
75. Sherin, J. E., Shiromani, P. J., McCarley, R. W. & Saper, C. B. Activation of 
ventrolateral preoptic neurons during sleep. Science 271, 216–219 (1996). 
76. Thalamocortical oscillations in the sleeping and aroused brain. - PubMed - NCBI. 
Available at: https://www.ncbi.nlm.nih.gov/pubmed/8235588. (Accessed: 19th April 
2019) 
77. Saper, C. B., Chou, T. C. & Scammell, T. E. The sleep switch: hypothalamic control 
of sleep and wakefulness. Trends Neurosci. 24, 726–731 (2001). 
78. Brunner, D. P., Dijk, D.-J., Münch, M. & Borbély, A. A. Effect of zolpidem on sleep 
and sleep EEG spectra in healthy young men. Psychopharmacology (Berl.) 104, 1–
5 (1991). 
79. Bäckberg, M., Ultenius, C., Fritschy, J.-M. & Meister, B. Cellular Localization of 
GABAA Receptor α Subunit Immunoreactivity in the Rat Hypothalamus: 
Relationship With Neurones Containing Orexigenic or Anorexigenic Peptides. J. 
Neuroendocrinol. 16, 589–604 (2004). 
80. Wisden, W., Laurie, D. J., Monyer, H. & Seeburg, P. H. The distribution of 13 
GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, 
mesencephalon. J. Neurosci. Off. J. Soc. Neurosci. 12, 1040–1062 (1992). 
81. May, A. C., Fleischer, W., Kletke, O., Haas, H. L. & Sergeeva, O. A. 
Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons. 
Br. J. Pharmacol. 170, 222–232 (2013). 
82. Vyazovskiy, V. V. & Tobler, I. Regional differences in NREM sleep slow-wave 
activity in mice with congenital callosal dysgenesis. J. Sleep Res. 14, 299–304 
(2005). 
83. de Andrés, I., Garzón, M. & Reinoso-Suárez, F. Functional Anatomy of Non-REM 
Sleep. Front. Neurol. 2, (2011). 
84. Weiergräber, M., Henry, M., Hescheler, J., Smyth, N. & Schneider, T. 
Electrocorticographic and deep intracerebral EEG recording in mice using a 
telemetry system. Brain Res. Brain Res. Protoc. 14, 154–164 (2005). 
85. Vassalli, A. & Franken, P. Hypocretin (orexin) is critical in sustaining theta/gamma-
rich waking behaviors that drive sleep need. Proc. Natl. Acad. Sci. 114, E5464–
E5473 (2017). 
86. Liu, X.-G., Zhang, B.-J., Xu, X.-H., Huang, Z.-L. & Qu, W.-M. Lesions of 
suprachiasmatic nucleus modify sleep structure but do not alter the total amount of 
daily sleep in rats. Sleep Biol. Rhythms 10, 293–301 (2012). 
87. Stephenson, R., Lim, J., Famina, S., Caron, A. M. & Dowse, H. B. Sleep-Wake 
Behavior in the Rat: Ultradian Rhythms in a Light-Dark Cycle and Continuous 
Bright Light. J. Biol. Rhythms 27, 490–501 (2012). 
88. Eckel-Mahan, K. & Sassone-Corsi, P. Phenotyping Circadian Rhythms in Mice. 
Curr. Protoc. Mouse Biol. 5, 271–281 (2015). 
48 
 
89. Bartos, M., Vida, I. & Jonas, P. Synaptic mechanisms of synchronized gamma 
oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 8, 45–56 (2007). 
90. An, K. et al. Altered Gamma Oscillations during Motor Control in Children with 
Autism Spectrum Disorder. J. Neurosci. 38, 7878–7886 (2018). 
91. Fitzgerald, P. J. & Watson, B. O. Gamma oscillations as a biomarker for major 
depression: an emerging topic. Transl. Psychiatry 8, (2018). 
92. Williams, S. & Boksa, P. Gamma oscillations and schizophrenia. J. Psychiatry 
Neurosci. JPN 35, 75–77 (2010). 
93. Kalemaki, K., Konstantoudaki, X., Tivodar, S., Sidiropoulou, K. & Karagogeos, D. 
Mice With Decreased Number of Interneurons Exhibit Aberrant Spontaneous and 
Oscillatory Activity in the Cortex. Front. Neural Circuits 12, 96 (2018). 
94. Ammanuel, S. et al. Heightened Delta Power during Slow-Wave-Sleep in Patients 
with Rett Syndrome Associated with Poor Sleep Efficiency. PLoS ONE 10, (2015). 
95. De Gennaro, L., Ferrara, M. & Bertini, M. The boundary between wakefulness and 
sleep: quantitative electroencephalographic changes during the sleep onset period. 
Neuroscience 107, 1–11 (2001). 
96. McCARLEY, R. W. & Massaquoi, S. G. Neurobiological structure of the revised 
limit cycle reciprocal interaction model of REM cycle control. J. Sleep Res. 1, 132–
137 (1992). 
97. Steriade, M., Datta, S., Paré, D., Oakson, G. & Curró Dossi, R. C. Neuronal 
activities in brain-stem cholinergic nuclei related to tonic activation processes in 
thalamocortical systems. J. Neurosci. Off. J. Soc. Neurosci. 10, 2541–2559 (1990). 
98. Hadjiyannakis, K., Ogilvie, R. D., Alloway, C. E. & Shapiro, C. FFT analysis of EEG 
during stage 2-to-REM transitions in narcoleptic patients and normal sleepers. 
Electroencephalogr. Clin. Neurophysiol. 103, 543–553 (1997). 
99. Dodson, E. R. & Zee, P. C. Therapeutics for Circadian Rhythm Sleep Disorders. 
Sleep Med. Clin. 5, 701–715 (2010). 
100. Garbazza, C. et al. Non-24-Hour Sleep-Wake Disorder Revisited - A Case Study. 
Front. Neurol. 7, 17 (2016). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 
 
CURRICULUM VITAE 
 
Austin J. Boren 
 
CONTACT INFORMATION  
 
 Email: Austin.John.Boren@gmail.com 
 
EDUCATION                                                                                                    
  
   University of Nevada, Las Vegas; 2016-present 
 Doctoral program, Experimental Psychology Neuroscience Emphasis   
 Expected graduation: 2022 
 GPA: 3.6 
 
   University of Nevada Las Vegas; 2014–2016 
Bachelor of arts degree, psychology 
Graduation: December 2015      
 Psychology GPA: 3.7  
   
   College of Southern Nevada; 2013–2014  
  Area of study; psychology 
 Transferred to University of Nevada, Las Vegas                                             
 
   University of Nevada, Reno; 2006–2010 
  Area of study; philosophy  
 Transferred to College of Southern Nevada  
 
RESEARCH EXPERIENCE  
 
  University of Nevada, Las Vegas Hines Group;  
           
Fall 2017-Current  
 Title: Graduate Student  
 Faculty Advisor: Rochelle Hines Ph.D 
 Responsibilities:  
           × Murine electroencephalogram analysis and collection. 
× Animal husbandry; breeding, weaning, and genotyping.   
 
University of Nevada, Las Vegas Molecular and Behavioral Neuroscience Labor-       
atory;                 
           Fall 2016–Fall 2017 
 Title: Graduate Student  
 Faculty Advisor: Jefferson W. Kinney Ph.D. 
Responsibilities:  
×  Behavioral assays including; Morris water maze, novel object recognition, open                   
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   field, tail flick, Barnes maze.   
×  Molecular assays including; Western blot, immunohistochemistry chemistry,      
   end point polymerase chain reaction, protein concentration assay.  
×  Animal husbandry including; breeding, weaning, and genotyping.   
 
University of Nevada, Las Vegas Molecular and Behavioral Neuroscience 
Laboratory;     
             
  Fall 2014–2015 
 Title: Undergraduate Research Assistant  
 Faculty Advisor: Jefferson W. Kinney Ph.D. 
Responsibilities:  
× Assisting in operation of behavioral assay including Morris water maze and      
  forced swim task. 
× Assisting in operation of biochemical assays including immunohistochemistry,    
  Western blot, polymerase chain reaction, and protein concentration assay.    
× Assisting in collecting tissue samples. 
× Assisting in handling research animals.  
× Organizing and conducting literature searches. 
 
PROFESSIONAL PRESENTATIONS 
 
1. Austin Boren, M. Khumnark, A. Contreras, D.J. Hines, R.M. Hines. Impared GA-    
BAergic signaling at the axon initial segment results in altered sleep architecture, 
bursting activity, and homeostatic sleep response. Society for Neuroscience 2018 
poster presentation.    
 
2. Austin Boren, Arnold Salazar, Andrew Murtishaw, Monica Bolton, Jefferson 
Kinney. GABA specific changes in a mouse model of Alzheimer’s disease. Society for 
Neuroscience 2017 poster presentation.  
 
3. Murtishaw, A.S., Bolton, M.M., Boren, A.J., Salazar, A.M., Toughlian, J.E., Ortiz, 
A.A., Kinney, J.W. Alterations of high-fat diet in CX3CR1 knockout mice on 
neuroinflammation, metabolic markers, and Alzheimer’s disease-related pathology. 
Society for the Study of Ingestive Behavior. Montreal, Canada, July 2017.  
 
4. Murtishaw, A.S., Bolton, M.M., Boren, A.J., Salazar, A.M., Toughlian, J.E., Ortiz, 
A.A., Kinney, J.W. High-fat diet induced insulin disruption in CX3CR1 knockout mice 
on dementia-related pathology. Society for Neuroscience annual meeting. 
Washington, D.C., November 2017. 
 
5. Andrew S. Murtishaw, Monica M. Bolton, Austin J. Boren, and Jefferson W. Kin         
ney. The effects of insulin impairments in CX3CR1 knockout mice on dementia-
related pathology and neuroinflammation. Society for Neuroscience annual meeting. 
San Diego, CA, November 2016.  
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6. Murtishaw, A.S., Heaney, C.F., Bolton, M.M., Belmonte, K.C.D, Langardt, M.A., 
Calvin K.N., Boren, A.J., & Kinney, J.W. A novel administration of systemic 
streptozotocin leads to alterations relevant to vascular dementia and Alzheimer’s 
disease. Society for Neuroscience annual meeting. Chicago, IL, October 2015. 
 
 
TEACHING EXPERINECE  
 
  Two sections Psychology 101 Spring 2019; instructor of records 
  
  Two sections Psychology 101 Fall 2018; instructor of records 
 
CAMPUS ACTIVITIES AND LEADERSHIP 
 
  Sheep Brain Lab Demonstration for Psychology 101 Students; Spring 2019 
 
  Guest Speaker at Developmental Psychology Monthly Meeting; Fall     
  2018  
 
Experimental psychology student council neuroscience emphases representa-       
tive; 2017- 2018 
 
  Outreach Undergraduate Mentoring Program; 2017- 2018 
 
  Presenting member of Neuroscience Journal Club; 2014–present 
   
  Physiology of Psychology Tutor (PSY 303); Spring 2015 
 
COMMUNITY OUTREACH 
 
  Side by side – Cleveland clinic; 2017 
Yearly educational experience for high school students to observe 
neuropsychiatric evaluations at the Cleveland clinic.  
 
  Nevada brain bee board member; 2017 
Yearly national competition for high school students on brain structure and 
function.   
   
    Brain awareness outreach; Spring 2015 – present  
Educational presentations and workshops for elementary school children on 
brain function and safety.  
 
AWARDS 
 
    Winner of Fall 2018 GPSA poster presentation forum 
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PROFESSIONAL REFERENCES 
    
   Rochelle Hines, Ph.D. 
 Assistant Professor, Department of Psychology, University of Nevada Las Vegas 
4505 S. Maryland Parkway, CBC-C 5030 Las Vegas, NV 89154-0530. 
Phone: 702-895-0187 
Email: Rochelle.hines@unlv.edu 
 
 
 Dustin Hines, Ph.D. 
Assistant Professor, Department of Psychology, University of Nevada Las Vegas 
4505 S. Maryland Parkway, CBC-C 5030 Las Vegas, NV 89154-0530. 
Phone: (702) 895-2208 
Email: dustin.hines@unlv.edu 
 
   James M. Hyman, Ph.D. 
Assistant Professor, Department of Psychology, University of Nevada Las Vegas  
4505 S. Maryland Parkway, CBC-C 5030 Las Vegas, NV 89154-0530. 
Phone: (702) 895-0109 
Email: james.Hyman@unlv.edu  
 
 
 
